PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
WENRX
Price
$65.55
Change
+$0.21 (+0.32%)
Updated
Jun 2 closing price
Net Assets
636.4M
Interact to see
Advertisement

PMBCX vs WENRX

Header iconPMBCX vs WENRX Comparison
Open Charts PMBCX vs WENRXBanner chart's image
PMBCX vs WENRX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. WENRX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and WENRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. WENRX (636M). PMBCX (0.00) and WENRX (0.00) have matching dividends . PMBCX was incepted earlier than WENRX: PMBCX (19 years) vs WENRX (12 years). PMBCX (1.71) is less costly to investors than WENRX (0.83). WENRX is a more actively managed with annual turnover of: 69.00 vs. PMBCX (13.70). WENRX has a lower initial minimum investment than PMBCX: WENRX (0) vs PMBCX (1000). WENRX annual gain was more profitable for investors over the last year : 5.71 vs. PMBCX (-15.11). PMBCX return over 5 years is better than : -9.16 vs. WENRX (-17.02).
PMBCXWENRXPMBCX / WENRX
Total Expense Ratio1.710.80214%
Annual Report Gross Expense Ratio1.710.83206%
Fund Existence19 years12 years-
Gain YTD-7.2527.485-97%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.6B636M3,868%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.115.71-265%
Returns for 3 years9.9732.0531%
Returns for 5 years-9.16-17.0254%
Returns for 10 years53.2048.64109%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity